Sandra Silberman
2020
In 2020, Sandra Silberman earned a total compensation of $341K as Chief Medical Officer at CNS Pharmaceuticals, a 25% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $38,900 |
|---|---|
| Option Awards | $127,058 |
| Salary | $175,000 |
| Total | $340,958 |
Silberman received $175K in salary, accounting for 51% of the total pay in 2020.
Silberman also received $38.9K in non-equity incentive plan and $127.1K in option awards.
Rankings
In 2020, Sandra Silberman's compensation ranked 11,907th out of 13,090 executives tracked by ExecPay. In other words, Silberman earned more than 9.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,907 out of 13,090 | 9th |
Division Manufacturing | 5,086 out of 5,617 | 10th |
Major group Chemicals And Allied Products | 2,074 out of 2,248 | 8th |
Industry group Drugs | 1,808 out of 1,948 | 7th |
Industry Pharmaceutical Preparations | 1,342 out of 1,453 | 8th |
Source: SEC filing on June 7, 2021.
Silberman's colleagues
We found two more compensation records of executives who worked with Sandra Silberman at CNS Pharmaceuticals in 2020.